louise phanstiel joins verastem board of directors  business wire louise phanstiel joins verastem board of directors september    am eastern daylight time cambridge massbusiness wireverastem inc nasdaq vstm a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells announced the appointment of s louise phanstiel to its board of directors louise phanstiel was most recently the president of specialty products at wellpoint inc and currently serves on the board of directors of myriad genetics and cedar sinai health system “louise is a healthcare leader with strategic and financial experience at the highest level” said christoph westphal md phd chairman and ceo of verastem “on behalf of lead director henri termeer and the verastem board of directors i welcome her and look forward to her contributions as we continue the development of our portfolio of cancer stem celltargeted candidates with the initiation of phase  trials planned for ” “verastem is leveraging its scientific expertise to eliminate cancer stem cells based on the groundbreaking work of dr robert weinberg” said louise phanstiel “this approach may be the key to providing a durable clinical response for serious cancers one of the most pressing issues in all of healthcare i am delighted to become a part of the team and work on this transformative approach to cancer treatment” s louise phanstiel has held several executive positions at wellpoint inc including president specialty products senior vice president chief of staff and corporate planning and senior vice president chief accounting officer and controller and cfo of all of wellpoint subsidiaries including blue cross of california prior to wellpoint ms phanstiel was a partner los angeles cluster insurance leader at coopers  lybrand llp she currently serves on the board of myriad genetics and cedar sinai health system ms phanstiel received her ba in accounting from golden gate university in san francisco ca about verastem inc verastem inc nasdaq vstm is a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells cancer stem cells are an underlying cause of tumor recurrence and metastasis for more information please visit wwwverastemcom forwardlooking statements this press release includes forwardlooking statements about the company’s strategy future plans and prospects including statements regarding the development of the company’s compounds and the expected timing of certain phase  clinical trials the words “anticipate” “believe” “estimate” “expect” “intend” “may” “plan” “predict” “project” “target” “potential” “will” “would” “could” “should” “continue” and similar expressions are intended to identify forwardlooking statements although not all forwardlooking statements contain these identifying words each forwardlooking statement is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statement applicable risks and uncertainties include the risks that the preclinical testing of the company’s compounds may not be predictive of the success of later clinical trials that the company will be unable to successfully complete the clinical development of its compounds that the development of the company’s compounds will take longer or cost more than planned and that the company’s compounds will not receive regulatory approval or become commercially successful products other risks and uncertainties include those identified under the heading “risk factors” in the company’s annual report on form k for the year ended december   and in any subsequent sec filings the forwardlooking statements contained in this presentation reflect the company’s current views with respect to future events and the company does not undertake and specifically disclaims any obligation to update any forwardlooking statements contacts verastem incinvestor contactbrian sullivan bsullivanverastemcomorfor verastem incmedia contactkari watson kwatsonmacbiocomcom release summary verastem appoints louise phanstiel to its board of directors contacts verastem incinvestor contactbrian sullivan bsullivanverastemcomorfor verastem incmedia contactkari watson kwatsonmacbiocomcom search advanced news search advanced news search log in sign up   mygn s louise phanstiel insider trades for myriad genetics inc bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close myriad genetics inc nasdaq mygn go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus myriad genetics inc after hours  quotes are delayed by  min jul    pm mygn quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual s louise phanstiel ms s l phanstiel cpa is independent director at verastem inc and independent director at myriad genetics inc she is on the board of directors at verastem inc myriad genetics inc and cedars sinai health system ms phanstiel was previously employed as chief financial officer cao svp  controller by blue cross of california presidentspecialty products by wellpoint inc and partner by coopers  lybrand llp she also served on the board at cedars sinai health system charles river laboratories inc and inveresk research group inc she received her undergraduate degree from golden gate university transactions date shares transaction value     award at  per share      disposition at  per share      gift at  per share      award at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr mark c capone president chief executive officer  director mr gary a king executive vice presidentinternational operations mr r bryan riggsbee chief financial officer treasurer  executive vp mr robert gardner harrison chief information officer dr jerry s lanchbury chief scientific officer mr richard s swartz executive vice president ms nicole lambert general managerurology business unit ms vicki fish general managerdermatology mr scott gleason investor relations contact mr ronald s rogers evpcorporate communications  media contact ms jayne b hart executive vice presidenthuman resources mr richard m marsh secretary executive vp  general counsel dr john tannahill henderson chairman dr walter a gilbert vice chairman mr lawrence c best independent director ms s louise phanstiel independent director dr heinrich dreismann independent director dr dennis h langer independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report abritish airways parent iags profit soars agermanys dax opens  lower at  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  louise phanstiel home press room profiles louise phanstiel profiles louise phanstiel louise mccrary phanstiel bs  lhd  managing director at phanstiel enterprises llc member board of directors at myriad genetics  verastem overcoming adversity a courageous adventure louise was in her midtwenties and had a couple of years of college under her belt she was feeling uncertain about her future with  in her pocket she got in her car and drove across the country working as a secretary to the purchasing agent for a small hair product manufacturer it didnt take long for the owner of the company to recognize louise had a knack for accounting the company soon offered to enroll her at golden gate university so she could take some accounting courses she worked during the day and went to school at night louise later landed a position as a secretary at a small cpa firm in la then she landed a job as a second year staff person at coopers  lybrand it was tough and she worked hard to catch up but she was recognizing along the way how much she loved the accounting profession as a partner at coopers  lybrand from  to  louise was responsible for managing the financial actuarial tax and advisory services for  clients she specialized in life and propertycasualty insurance high technology and nonprofit higher education in  she was drawn to a new opportunity at wellpoint inc where she would spend the next  years in her first position she wore several hats with titles to match including senior vice president chief accounting officer and controller and cfo of its major subsidiaries she was responsible for corporatewide planning budgeting and forecasting and juggled a variety of responsibilities including redesigning the companys reporting systems to support expansion to a national fortune  company it was during the next several years at wellpoint that louise had some of her greatest successes as a strategic leader and as president of specialty products making a difference in every position she has worked toward making a difference she challenges herself and others along the way louise has been involved in a variety of philanthropic efforts that include education medical research and animal rights she has served on numerous boards throughout the years including companies such as myriad genetrics verastem inveresk research group i have a dream foundation and cedarssinai health systems in  louise was the recipient of the circle of orange award recognizing leaders who shape the future and create positive change syracuse students who were recipients of the phanstiel scholar program tell stories about how louise makes a difference with more than just dollars she guides them encourages them to focus on their career and she considers them her family she loves to share how her grandmother lived a life of ‘selfless and silent philanthropy and was her first example of giving in  golden gate university recognized louise as alum of the year she delivered the ggu commencement speech in  she shares the importance of being the ceo of me and reinforces the importance of having a plan but to be ready for adversity disappointment make midcourse corrections and reevaluate plans along the way her career mantra act like a lady think like a man and work like a dog creative projects in  louise retired and also opened the door for new adventures community involvement and other handson projects such as website design a blog and youtube channel of instructional cooking videos you can find all her creative work on wwwmyfoodvoiceme considering ggu request info gguyou  online request form infogguedu apply apply online download application read our faq   s phanstiel  directors and boards skip to main content login username  password  go  forgot password not a subscriber search form search toggle navigation ms s louise phanstielshe has held management positions with wellpoint inc including svp chief accounting officer and controller and most recently president of specialty products she formerly was a partner at coopers  lybrand also is a director of myriad genetics and cedar sinai health system fourth quarteradded to verastem inc  cambridge maverastem is a biopharmaceutical company focused on treating breast and other cancers vstm s louise phanstiel insider trades for verastem inc bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close verastem inc nasdaq vstm go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus verastem inc market closed  quotes are delayed by  min jul    pm vstm quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual s louise phanstiel ms s l phanstiel cpa is independent director at verastem inc and independent director at myriad genetics inc she is on the board of directors at verastem inc myriad genetics inc and cedars sinai health system ms phanstiel was previously employed as chief financial officer cao svp  controller by blue cross of california presidentspecialty products by wellpoint inc and partner by coopers  lybrand llp she also served on the board at cedars sinai health system charles river laboratories inc and inveresk research group inc she received her undergraduate degree from golden gate university transactions date shares transaction value     acquisition at  per share      acquisition at  per share      acquisition at  per share      acquisition at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr robert m forrester president chief executive officer  director mr daniel w paterson chief operating officer ms julie b feder chief financial officer dr jonathan pachter chief scientific officer mr joseph chiapponi vice presidentfinance mr michael ferraresso vice presidentcommercial operations dr hagop youssoufian headhematology  oncology development mr steven bloom vice presidentcorporate development dr eric k rowinsky director dr michael g kauffman lead director mr brian sullivan headcorporate development  investor relations mr bruce j wendel independent director ms alison francis lawton independent director mr timothy joseph barberich independent director ms s louise phanstiel independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aubs credit suisse profits up after strategy shift astudent loan companies to feds tell states to stop regulating us abritishmade seedlip aims to woo the nondrinking crowd aset yourself up to get the most out of retirement aeuropean stocks sell off as ubs falls tech worries weigh aprince william and kate middleton are hiring— though not for these weird five royal family jobs arightmove profit rises on ad sales abank of ireland profit falls to restart dividend ahow do i get a reverse mortgage aus tech stocks shape up for another day of selling after amazon disappoints athis city’s subway system will soon run entirely on renewable energy a‘skinny’ repeal of obamacare fails to pass in latenight senate vote aubs credit suisse profit up after strategic shift arenault firsthalf profit leaps on higher volume aftse  under pressure as bt pushed lower afrances cac  falls  dropping further in early friday trade abarclays falls  after earnings report abritish airways parent iag rises  after quarterly profit report abritish airways parent iags profit soars agermanys dax opens  lower at  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  howard and louise phanstiel skip to main content internal resources about maxwell departments  programs institutes  centers news  events alumni office career services giving to maxwell prospective students department navigation aboutpeopleprogramscontacteventsshared services guide maxwell  campbell programscampbell conversationscampbell debatescampbell lectureshoward g and s louise phanstiel chair in strategic management and leadershipphanstiel chairhoward g and s louise phanstieldordain lecturethe louis a bantle chair in business and government policyresearch experience in ethics and healthsawyer law and politics programstate of democracythe tanner lecture series on ethics citizenship and public responsibility howard and louise phanstiel      howard phanstiel joined pacificare health systems as executive vice president and chief financial officer in july   in october  he was named to pacificares board of directors and in december  he was appointed president and chief executive officer  in february  pacificare’s board of directors elected phanstiel chairman and ceo  in december  he led pacificare in its merger with unitedhealth group prior to retiring in april  under phanstiel’s leadership pacificare transformed into a leading consumer health organization offering a variety of consumerdriven programs that provide more affordable and flexible health insurance and related products  as chief executive of one of the nation’s largest medicare advantage companies phanstiel was frequently interviewed by the national news media on a wide range of industryrelated issues  he remains actively involved in health care public policy issues  prior to joining pacificare phanstiel was chairman and ceo of arv assisted living inc of costa mesa calif   previously he was executive vice president finance and information services at wellpoint health networks inc in woodland hills calif  phanstiel has also held various executive and management positions with prudential bache international bank and prudential bache securities marine midland banks sallie mae and citibank na  phanstiel’s broad health care and management experience also includes the public sector at both the state and federal level  he has served as a director of the office of management and budget omb of the health care financing administration hcfa in the us department of health education and welfare  he was also division chief of the office of fiscal affairs at the illinois bureau of budget and executive budget officer at the wisconsin bureau of planning and budget  phanstiel received his bachelor of arts degree in political science from syracuse university in new york and a master’s degree in public administration from the university’s maxwell school of citizenship and public affairs  he currently serves on the maxwell school advisory board and is vice chair of the syracuse university board of trustees  additionally phanstiel serves on the institutional advancement athletic advisory and executive committees for syracuse university he also is a cochairman of the syracuse university capital campaign    in  phanstiel was recognized for significant achievements and contributions to the managed care sector by who’s who in managed health care  in  and  he was recognized as a patriotic employer by the national committee for employer support of the guard and reserve for pacificare’s generous support of its employees in the military reserve and their families in  phanstiel was honored at the third annual american heart association’s corazones unidoshearts united gala for his dedication and support provided to the latino community  phanstiel and pacificare have been honored with the orange county black chamber of commerce  corporation of the year award by latinastyle in  and  as one of the “ best companies for latinas” to work by hispanic magazine as one of their  and  “corporate ” as one of the “best places for hispanics” to work and by asian enterprise magazine in  and  as one of the “best companies to work for asian americans”  in  phanstiel and pacificare received the seven seals award for patriotic employers and pacificare was selected as one of the “ top employers for minorities” by fortune magazine  and in march  he received the director of the year award from the forum for corporate directors   phanstiel and his wife louise are also active in several philanthropic endeavors especially in support of educational institutions at the elementary high school and university levels in october  the phanstiel’s announced a gift to su in the form an educational grant program known as the phanstiel scholars program  this grant provides assistance to su students from middle income backgrounds that have demonstrated examples of academic success and community leadership  for syracuse university phanstiel is vice chairman of the board of trustees and serves on the institutional advancement committee the executive committee and the athletics board of directors he also volunteered to be a cochair of the su giving campaign which recently successfully finished at over  billion outside of syracuse university phanstiel currently serves as chairman of united online a leading provider of consumer products and services over the internet since november  and as a director since october    s louise phanstiel  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in s louise phanstiel board member at myriad genetics inc view full profile are you s louise phanstiel claim your profile   sign up for equilar atlas and view s louise phanstiels full profile with equilar atlas you can identify corporate executives in s louise phanstiels network and community follow changes in s louise phanstiels employment and moneyinmotion connect with s louise phanstiel through your network of contacts s louise phanstiels executive work history current board member myriad genetics inc past to view s louise phanstiels complete executive work history sign up now education ba golden gate university age      s louise phanstiels biography s louise phanstiel age  is a class i director who has served as a member of our board of directors since september  ms phanstiel held several important positions at wellpoint inc from  to  including president specialty products  to  senior vice president chief of staff and corporate planning in the office of the chairman  to  and senior vice president chief accounting officer controller and chief financial officer for all wellpoint inc subsidiaries including blue cross of california  to  previously ms phanstiel was a partner at the international services firm of coopers  lybran  read more s louise phanstiel age  is a class i director who has served as a member of our board of directors since september  ms phanstiel held several important positions at wellpoint inc from  to  including president specialty products  to  senior vice president chief of staff and corporate planning in the office of the chairman  to  and senior vice president chief accounting officer controller and chief financial officer for all wellpoint inc subsidiaries including blue cross of california  to  previously ms phanstiel was a partner at the international services firm of coopers  lybrand where she served clients in life and propertycasualty insurance high technology and higher education ms phanstiel has served on the board of directors of myriad genetics since september  and formerly served on the boards of directors of inveresk research group inc and charles river laboratories inc ms phanstiel received a ba degree in accounting from golden gate university and is a certified public accountant the board of directors believes that ms phanstiels qualifications to sit on the board include her significant financial investment and management expertise and her experience managing and serving as a director of publicly traded companies source verastem inc on    sign up for equilar atlas and view s louise phanstiels full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like s louise phanstiel more specifically youll be able to identify corporate executives in s louise phanstiels network and community follow changes in s louise phanstiels employment and moneyinmotion connect with s louise phanstiel through your network of conections view full profile   search for over  executive profiles bio example s louise phanstiel s louise phanstiels connections  sign up now to view s louise phanstiels  connections » jacquelyn m ward board member sysco corporation leonard d schaeffer board member walgreens boots alliance inc paul a friedman chairman president and chief executive officer madrigal pharmaceuticals inc richard h aldrich board member ovascience inc larry c glasscock board member zimmer biomet holdings inc john sherman board member albemarle ramiro g peru board member sm energy company joan e herman board member healthsouth corporation george a schaefer board member anthem inc john k clarke former board member alnylam pharmaceuticals inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   the maxwell school of syracuse university skip to main content internal resources about maxwell departments  programs institutes  centers news  events alumni office career services giving to maxwell prospective students global citizens join a culturally diverse community of students pursue research and internships around the world and study in our inhouse interdisciplinary institute for global affairs crossing boundaries learn from a diverse faculty connecting across disciplines to assure that social sciences inform a public affairs career and that scholarship never forgets the tangible ends it serves career oriented earn a degree that leaves you not just trained but bigpicture wise and cando savvy the maxwell blend of theory policy and practice prepares you to launch a truly great career alumnicentric enter a network of influential alumni famously loyal to maxwell to one another and to the idea that welleducated public servants change the world connected to the world benefit from frequent visiting leaders and intellectuals — and from our dc headquarters at csis where you will connect to world difference makers ‹ › for students interested in graduate professional degrees efficiently paced ir and mpa programs centered around transferrable leadership skills and drawing on maxwells interdisciplinary social science environment graduate social science degrees scholarly masters and phd programs benefiting from nine interdisciplinary research institutes and maxwells strong public policy emphases undergraduate majors  minors social science degrees and electives featuring the same faculty and facilities as the graduate programs and steeped in interdisciplinary citizenship studies news featured faculty alumni students research dutkowsky questions m grants to rehab aging downtowns in the nyt su to invest  million in academic programs student experience banks discusses prospect of kushnerrussia fisa taps with wired burman discusses private sector interests in tax reform with wcny mitra pens oped for indian express on pm modis economic reforms gadarian discusses news terrorism and policy impact on cbc the national  more faculty news logan strother article on confederate symbols published in lse blog alex lynch  ba psccce featured in local media for cce project maxwell school honors new graduates at  mpa convocation  more alumni news logan strother article on confederate symbols published in lse blog phd student jennifer brooks receives asa grad student paper award van der vort  ma psc publishes article on playful protesting  more student news purser report on treatment of dairy farmworkers cited in ny times schnell piece on transparency anticorruption published in governance logan strother article on confederate symbols published in lse blog  more research news mitra pens oped for indian express on pm modis economic reforms gadarian discusses news terrorism and policy impact on cbc the national reeher comments on health care reform bipartisanship in the hill purser report on treatment of dairy farmworkers cited in ny times schnell piece on transparency anticorruption published in governance maxwell and cornell cohost workshop on refugees in the classroom andrew cohen discusses history of internships on marketplace  more maxwell news the maxwell school of citizenship and public affairs is syracuse university’s home for innovative interdisciplinary teaching and research in the social sciences public policy public administration and international relations it is the nation’s  ranked school for graduate education in public affairs us news and is home also to undergraduate social science degrees and nine interdisciplinary research centers focused on topical areas within public affairs myriad genetics  about myriad  inside myriad menu toggle navigation patients and families disease info hereditary breast cancer hereditary colon cancer hereditary endometrial cancer lung cancer melanoma hereditary ovarian cancer hereditary pancreatic cancer prostate cancer rheumatoid arthritis your questions about disease what’s my risk do i have a disease how aggressive is my disease how should i treat my disease   learn about the quiz genetic testing  genes  disease benefits of genetic testing genetic testing faqs the myriad advantage   view product details the myriad difference the myriad promise financial assistance program customer service your privacy patient resources mysupport™ hereditary cancer quiz real patient stories patient support groups find a healthcare provider available for free on the app store healthcare professionals disease education hereditary breast cancer hereditary colon cancer hereditary endometrial cancer lung cancer melanoma hereditary ovarian cancer hereditary pancreatic cancer prostate cancer rheumatoid arthritis improving patient care predicting disease diagnosing disease assessing prognosis guiding personalized treatment learn more about genetic testing genetic testing process genetic tests for hereditary cancers genetic testing faqs policy on genetic information financial assistance program view product details professional resources myriadpro hereditary cancer quiz order a test kit myriad lab certificates order a test kit need help myriad customer service myriad    cscommentsmyriadcom learn about the quiz insurance providers myriad managed care decrease costs while improving patient wellbeing learn more » contact us today » lab accuracy accurate test results drive optimal treatments myvision® » databases » accreditations » hereditary cancer » prostate cancer » breast cancer » rheumatoid arthritis » melanoma » mental illness » research partnerships research at myriad view myriad pipeline partnerships  licensing companion diagnostics partnerships other industry partnerships licensing at myriad academic collaborations interested in collaborating with myriad industry partners contact andrew drew gibbs senior director business development myriad genetics inc   dgibbsmyriadcom academic partners contact john gill jd mba senior director business development myriad genetics inc   jgillmyriadcom news center media newsroom media kits executive bios news releases events  presentations ron rogers evp corporate communications   rrogersmyriadcom investor information investor faqs news releases events  presentations financial reporting stock information scott gleason vp investor relations   sgleasonmyriadcom multimedia library videos infographics images media kits view infographic myriad matters blog our policy on patient privacy video – pioneering advances in personalized medicine corporate fact sheet careers at myriad the myriad culture our employees our community our diversity video –  ragnar race joining the myriad team current openings internships employment benefits myriad fact sheet about myriad inside myriad myriad ataglance company fact sheet history executive bios board of directors company milestones myriad around the world global presence international distributors international distributor map locations  directions directions to myriad directions to myriad rbm directions to myriad international directions to assurex health directions to crescendo bioscience myriad cares the myriad pledge the myriad promise corporate social responsibility financial assistance program patient advocacy patient support groups policy on genetic information contact us  myriad   myriad genetics inc  wakara way salt lake city ut  corporate fact sheet inside myriad inside myriad overview myriad ataglance company fact sheet history executive bios board of directors company milestones myriad around the world overview global presence international distributors locations  directions overview directions to myriad directions to myriad rbm directions to myriad international directions to crescendo bioscience directions to assurex health contact us corporate offices international offices about myriad  inside myriad  overview share at myriad our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the company’s history myriad is focused on revolutionizing patient care through the discovery development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties since  myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease more than  million patients have already benefited from myriad’s hereditary cancer genetic testing which helps healthcare professionals better manage and tailor medical care today myriad continues this strong tradition we are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases we also are focused on expanding internationally in an effort to broaden our geographic footprint and provide our lifesaving products and services to patients and healthcare professionals around the world related informationmyriad ataglancecompany milestonesmyriad around the world myriad fact sheet at myriad we are committed to making products that improve people’s lives hereditary cancer knowing your cancer family history can inform your medical decisions and improve the outcomes of your healthcare terms of use privacy policy data protection and privacy statement site map contact us   louise phanstiel joins verastem board of directors  aol finance louise phanstiel joins verastem board of directors share businesswirevia the motley fool aolcom sep th  am louise phanstiel joins verastem board of directorscambridge massbusiness wire verastem inc nas vstm a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells announced the appointment of s louise phanstiel to its board of directors louise phanstiel was most recently the president of specialty products at wellpoint inc and currently serves on the board of directors of myriad genetics and cedar sinai health systemlouise is a healthcare leader with strategic and financial experience at the highest level said christoph westphal md phd chairman and ceo of verastem on behalf of lead director henri termeer and the verastem board of directors i welcome her and look forward to her contributions as we continue the development of our portfolio of cancer stem celltargeted candidates with the initiation of phase  trials planned for verastem is leveraging its scientific expertise to eliminate cancer stem cells based on the groundbreaking work of dr robert weinberg said louise phanstiel this approach may be the key to providing a durable clinical response for serious cancers one of the most pressing issues in all of healthcare i am delighted to become a part of the team and work on this transformative approach to cancer treatments louise phanstiel has held several executive positions at wellpoint inc including president specialty products senior vice president chief of staff and corporate planning and senior vice president chief accounting officer and controller and cfo of all of wellpoint subsidiaries including blue cross of california prior to wellpoint ms phanstiel was a partner los angeles cluster insurance leader at coopers  lybrand llp she currently serves on the board of myriad genetics and cedar sinai health system ms phanstiel received her ba in accounting from golden gate university in san francisco caabout verastem incverastem inc  nas vstm is a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells cancer stem cells are an underlying cause of tumor recurrence and metastasis for more information please visit wwwverastemcomforwardlooking statementsthis press release includes forwardlooking statements about the companys strategy future plans and prospects including statements regarding the development of the companys compounds and the expected timing of certain phase  clinical trials the words anticipate believe estimate expect intend may plan predict project target potential will would could should continue and similar expressions are intended to identify forwardlooking statements although not all forwardlooking statements contain these identifying words each forwardlooking statement is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statement applicable risks and uncertainties include the risks that the preclinical testing of the companys compounds may not be predictive of the success of later clinical trials that the company will be unable to successfully complete the clinical development of its compounds that the development of the companys compounds will take longer or cost more than planned and that the companys compounds will not receive regulatory approval or become commercially successful products other risks and uncertainties include those identified under the heading risk factors in the companys annual report on form k for the year ended december   and in any subsequent sec filings the forwardlooking statements contained in this presentation reflect the companys current views with respect to future events and the company does not undertake and specifically disclaims any obligation to update any forwardlooking statementsverastem incinvestor contactbrian sullivan bsullivanverastemcomorforverastem incmedia contactkari watson kwatsonmacbiocomcomkeywords   united states  north america  massachusettsindustry keywords the article louise phanstiel joins verastem board of directors originally appeared on foolcom try any of our foolish newsletter services free for  days we fools may not all hold the same opinions but we all believe that considering a diverse range of insights makes us better investors the motley fool has a disclosure policycopyright     the motley fool llc all rights reserved the motley fool has a disclosure policy tags dfmain read full story cant get enough business news sign up for finance report by aol and get everything from retailer news to the latest ipos delivered directly to your inbox daily subscribe to our other newsletters emails may offer personalized content or ads learn more you may unsubscribe any time from our partners  snapchats that are so stupid you cant help but laugh woman finds an animal stuck in the grill of her car before realizing its still alive the  creepiest urban legends on the internet are scaring the crap out of everyone the latest from our partners online savings accounts earn you s here’s why mortgage rates remain at month low – lock in now  cd rates that will skyrocket your finances the fastest way to pay off your mortgage veterans could receive up to  with these va benefits crush your debt by refinancing to a  year fixed loan pay no interest until august  with this card rack up unlimited miles with this astonishing credit card an incredible  intro bonus just for using this card donald trump and  other most hated us politicians of all time  things you should never buy at whole foods  vehicles rich people want the most that you probably drive too owe less than k on your home dont miss this unique opportunity how to get a harp loan before it expires in september how to pay off your house asap easy tip farmer hears squeaking in her barn posts this on facebook to everyones disbelief two women find an abandoned dog tied to a pole and a crushing note lying beside him parents make horrifying discovery after toddler hears a strange voice in the recommended for youreport steve bannon pushing for marginal tax rate increase on the extremely wealthythese hotels will provide the most stunning views of the great american eclipseone of the most controversial parts of the republican tax plan is deada japanese doctor who studied longevity — and lived to  — said if you must retirent the runway launches sameday delivery in new york cityjeff bezos is the worlds richest personnavy helps rescue  wild elephants washed out to seabuffalo wild wings is killing one of customers favorite dealsmarketsusglobalscurrenciesdjianasdaqsp nikkei hang sengdaxusd per eurusd per chfjpy per usdgbp per usdall index data provided on a  minute delaymore to explorefrom our partnershow do we encourage more women in stemquick  dirty tipswhat to do when pests strikequick  dirty tips reasons you cant focusquick  dirty tips signs its time to let go of a friendsuccess magazinephrases from obsolete technologyquick  dirty tipseffortless ways to organize your drawersquick  dirty tipsshould you drink tap or bottled waterquick  dirty tipshow quickly can you expect to see muscle gainsquick  dirty tipsby pubexchange fri jul  °f set your location city state or zip change weather location mail search sign in  join my account log out news entertainment finance lifestyle games video shop myriad genetics  about myriad  inside myriad menu toggle navigation patients and families disease info hereditary breast cancer hereditary colon cancer hereditary endometrial cancer lung cancer melanoma hereditary ovarian cancer hereditary pancreatic cancer prostate cancer rheumatoid arthritis your questions about disease what’s my risk do i have a disease how aggressive is my disease how should i treat my disease   learn about the quiz genetic testing  genes  disease benefits of genetic testing genetic testing faqs the myriad advantage   view product details the myriad difference the myriad promise financial assistance program customer service your privacy patient resources mysupport™ hereditary cancer quiz real patient stories patient support groups find a healthcare provider available for free on the app store healthcare professionals disease education hereditary breast cancer hereditary colon cancer hereditary endometrial cancer lung cancer melanoma hereditary ovarian cancer hereditary pancreatic cancer prostate cancer rheumatoid arthritis improving patient care predicting disease diagnosing disease assessing prognosis guiding personalized treatment learn more about genetic testing genetic testing process genetic tests for hereditary cancers genetic testing faqs policy on genetic information financial assistance program view product details professional resources myriadpro hereditary cancer quiz order a test kit myriad lab certificates order a test kit need help myriad customer service myriad    cscommentsmyriadcom learn about the quiz insurance providers myriad managed care decrease costs while improving patient wellbeing learn more » contact us today » lab accuracy accurate test results drive optimal treatments myvision® » databases » accreditations » hereditary cancer » prostate cancer » breast cancer » rheumatoid arthritis » melanoma » mental illness » research partnerships research at myriad view myriad pipeline partnerships  licensing companion diagnostics partnerships other industry partnerships licensing at myriad academic collaborations interested in collaborating with myriad industry partners contact andrew drew gibbs senior director business development myriad genetics inc   dgibbsmyriadcom academic partners contact john gill jd mba senior director business development myriad genetics inc   jgillmyriadcom news center media newsroom media kits executive bios news releases events  presentations ron rogers evp corporate communications   rrogersmyriadcom investor information investor faqs news releases events  presentations financial reporting stock information scott gleason vp investor relations   sgleasonmyriadcom multimedia library videos infographics images media kits view infographic myriad matters blog our policy on patient privacy video – pioneering advances in personalized medicine corporate fact sheet careers at myriad the myriad culture our employees our community our diversity video –  ragnar race joining the myriad team current openings internships employment benefits myriad fact sheet about myriad inside myriad myriad ataglance company fact sheet history executive bios board of directors company milestones myriad around the world global presence international distributors international distributor map locations  directions directions to myriad directions to myriad rbm directions to myriad international directions to assurex health directions to crescendo bioscience myriad cares the myriad pledge the myriad promise corporate social responsibility financial assistance program patient advocacy patient support groups policy on genetic information contact us  myriad   myriad genetics inc  wakara way salt lake city ut  corporate fact sheet inside myriad inside myriad overview myriad ataglance company fact sheet history executive bios board of directors company milestones myriad around the world overview global presence international distributors locations  directions overview directions to myriad directions to myriad rbm directions to myriad international directions to crescendo bioscience directions to assurex health contact us corporate offices international offices about myriad  inside myriad  overview share at myriad our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the company’s history myriad is focused on revolutionizing patient care through the discovery development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties since  myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease more than  million patients have already benefited from myriad’s hereditary cancer genetic testing which helps healthcare professionals better manage and tailor medical care today myriad continues this strong tradition we are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases we also are focused on expanding internationally in an effort to broaden our geographic footprint and provide our lifesaving products and services to patients and healthcare professionals around the world related informationmyriad ataglancecompany milestonesmyriad around the world myriad fact sheet at myriad we are committed to making products that improve people’s lives hereditary cancer knowing your cancer family history can inform your medical decisions and improve the outcomes of your healthcare terms of use privacy policy data protection and privacy statement site map contact us   myriad genetics  about myriad  board of directors menu toggle navigation patients and families disease info hereditary breast cancer hereditary colon cancer hereditary endometrial cancer lung cancer melanoma hereditary ovarian cancer hereditary pancreatic cancer prostate cancer rheumatoid arthritis your questions about disease what’s my risk do i have a disease how aggressive is my disease how should i treat my disease   learn about the quiz genetic testing  genes  disease benefits of genetic testing genetic testing faqs the myriad advantage   view product details the myriad difference the myriad promise financial assistance program customer service your privacy patient resources mysupport™ hereditary cancer quiz real patient stories patient support groups find a healthcare provider available for free on the app store healthcare professionals disease education hereditary breast cancer hereditary colon cancer hereditary endometrial cancer lung cancer melanoma hereditary ovarian cancer hereditary pancreatic cancer prostate cancer rheumatoid arthritis improving patient care predicting disease diagnosing disease assessing prognosis guiding personalized treatment learn more about genetic testing genetic testing process genetic tests for hereditary cancers genetic testing faqs policy on genetic information financial assistance program view product details professional resources myriadpro hereditary cancer quiz order a test kit myriad lab certificates order a test kit need help myriad customer service myriad    cscommentsmyriadcom learn about the quiz insurance providers myriad managed care decrease costs while improving patient wellbeing learn more » contact us today » lab accuracy accurate test results drive optimal treatments myvision® » databases » accreditations » hereditary cancer » prostate cancer » breast cancer » rheumatoid arthritis » melanoma » mental illness » research partnerships research at myriad view myriad pipeline partnerships  licensing companion diagnostics partnerships other industry partnerships licensing at myriad academic collaborations interested in collaborating with myriad industry partners contact andrew drew gibbs senior director business development myriad genetics inc   dgibbsmyriadcom academic partners contact john gill jd mba senior director business development myriad genetics inc   jgillmyriadcom news center media newsroom media kits executive bios news releases events  presentations ron rogers evp corporate communications   rrogersmyriadcom investor information investor faqs news releases events  presentations financial reporting stock information scott gleason vp investor relations   sgleasonmyriadcom multimedia library videos infographics images media kits view infographic myriad matters blog our policy on patient privacy video – pioneering advances in personalized medicine corporate fact sheet careers at myriad the myriad culture our employees our community our diversity video –  ragnar race joining the myriad team current openings internships employment benefits myriad fact sheet about myriad inside myriad myriad ataglance company fact sheet history executive bios board of directors company milestones myriad around the world global presence international distributors international distributor map locations  directions directions to myriad directions to myriad rbm directions to myriad international directions to assurex health directions to crescendo bioscience myriad cares the myriad pledge the myriad promise corporate social responsibility financial assistance program patient advocacy patient support groups policy on genetic information contact us  myriad   myriad genetics inc  wakara way salt lake city ut  corporate fact sheet board of directors understanding myriad investor faqs corporate governance executive bios board of directors news releases all financial news corporate news product news pipeline news events  presentations financial scientific financial reporting gaap to nongaap reconciliation sec filings annual reports quarterly results key ratios stock information current share price historic share price investment calculator dividend history analyst coverage about myriad  inside myriad  board of directors john t henderson mdchairman of the boardjohn t henderson md was elected as chairman of the board in april  he previously served as a director of the company effective may  dr henderson was with pfizer for over  years most recently as a vice president in the pfizer pharmaceuticals group dr henderson previously held vice presidential level positions with pfizer in research and development in europe and later in japan he was also vice president medical for europe us and international pharmaceuticals group dr henderson earned his bachelors and medical degree from the university of edinburgh and is a fellow of the royal college of physicians edmark capone president and ceo mark c capone is president and ceo of myriad genetics he previously served as president of myriad genetic laboratories from march  to june  mr capone joined the company in october  prior to joining myriad he served  years with eli lilly and company where he held positions as product development manager manufacturing plant manager and area sales director mr capone received his bs degree in chemical engineering from penn state university graduating with highest distinction his ms degree in chemical engineering from massachusetts institute of technology and his ms in management from massachusetts institute of technology he also earned a master of science in management from the sloan school of management at the massachusetts institute of technology in  mr capone was elected outstanding engineering alumnus at penn state and he is a member of the industrial and professional advisory council at penn state  he currently serves on the board of the american clinical laboratory association mr capone also is a member of the board of trustees for pioneer theatre company in salt lake city lawrence c best directorlawrence c best a director of the company since september  joined boston scientific corporation in  and served for  years as the executive vice presidentfinance  administration and chief financial officer prior to joining boston scientific mr best was a partner in the accounting firm of ernst  young where he specialized in serving multinational companies in the high technology and life sciences fields he served a twoyear fellowship at the sec from  to  and a oneyear term as a white houseappointed presidential exchange executive in washington dc he currently serves on the board of directors of haemonetics corp and is a founding director of the presidents council at massachusetts general hospital mr best received a bba degree from kent state universityheiner dreismann phddirector heiner dreismann phd joined the company in june  dr dreismann had a successful career at the roche group from  to  where he held several senior positions including president and ceo of roche molecular systems head of global business development for roche diagnostics and member of roches global diagnostic executive committee dr dreismann currently serves on the boards of several public and private health care companies he earned a master of science degree in biology and his doctor of philosophy degree in microbiologymolecular biology summa cum laude from westfaelische wilhelms university the university of münster in germany walter gilbert phddirector vice chairman of the board walter gilbert phd vice chairman of the board of directors joined the company as a founding scientist in march  dr gilbert won the nobel prize in chemistry in  for his contributions to the development of dna sequencing technology he was a founder of biogen inc and its chairman of the board and chief executive officer from  to  as well as the carl m loeb university professor at harvard university presently he is a general partner of bioventures investors dennis langer md jddirector dennis langer md jd is a director of the company as of may  he was previously senior vice president in research and development at glaxosmithkline and has a broad base of experience in innovative rd companies such as eli lilly abbott and gd searle he is also a clinical professor at the department of psychiatry georgetown university school of medicine dr langer has earned a jd cum laude from harvard law school an md from georgetown university school of medicine and a ba in biology from columbia university s louise phanstiel director s louise phanstiel joined the company in september  ms phanstiel held several important positions at wellpoint inc from  to  including president specialty products  to  senior vice president chief of staff and corporate planning in the office of the chairman  to  and senior vice president chief accounting officer controller and chief financial officer for all wellpoint inc subsidiaries including blue cross of california  to  previously ms phanstiel was a partner at the international services firm of coopers and lybrand where she served clients in life and propertycasualty insurance high technology and higher education ms phanstiel currently serves on the board of directors of verastem inc and the board of trustees of the stony brook foundation ms phanstiel received a ba degree in accounting from golden gate university and is a certified public accountant media contact ron rogers evp corporate communications   rrogersmyriadcom learn how prolaris personalizes prostate cancer treatment stock quotenasdaqmygn  intraday high   week high  intraday low   week low  volume   pm est on jul  delayed at least  minutesprovided by esignal personalizing prostate cancer treatment prolaris measures cancer aggressiveness to help personalize treatment for men with prostate cancer widgetized area  add widget texthtml via the wp admin using newsroomrightarea terms of use privacy policy data protection and privacy statement site map contact us